Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Wei, Hua ^a   Desouki, Mohamed Mokhtar ^b   Lin, Shufei ^a   Xiao, Dakai ^a   Franklin, Renty B ^a,c   Feng, Pei ^a,c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; ZINC; METALLOTHIONEIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; ANTIBODY SPECIFICITY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; BLOTTING, WESTERN; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METALLOTHIONEIN; ORGAN SPECIFICITY; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; ZINC;

EID: 40749088819     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-7     Document Type: Article

References (41)

1. Frassinetti S Bronzetti G Caltavuturo L Cini M Croce CD The role of zinc in life: A review J Environ Pathol Toxicol Oncol 2006, 25:597-610. 17073562
2. MacDonald RS The role of zinc in growth and cell proliferation J Nutr 2000, 130:1500S-1508S. 10801966
3. Yang CS Research on esophageal cancer in China: A review Cancer Res 1980, 40:2633-2644. 6992989
4. Fong LY Jiang Y Farber JL Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice Carcinogenesis 2006, 27:1489-1496. 10.1093/carcin/bgl012 16543248
5. Costello LC Franklin RB Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer Prostate 1998, 35:285-296. 10.1002/ (SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F 9609552
6. Feng P Liang JY Li TL Guan ZX Zou J Franklin R Costello LC Zinc induces mitochondria apoptogenesis in prostate cells Mol Urol 2000, 4:31-36. 10851304
7. Feng P Li TL Guan ZX Franklin RB Costello LC Direct effect of zinc on mitochondrial apoptogenesis in prostate cells Prostate 2002, 52:311-318. 10.1002/pros.10128 12210492
8. Kondoh M Tasaki E Araragi S Takiguchi M Higashimoto M Watanabe Y Sato M Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells Eur J Biochem 2002, 269:6204-6211. 10.1046/ j.1432-1033.2002.03339.x 12473116
9. Rudolf E Rudolf K Cervinka M Zinc induced apoptosis in HEP-2 cancer cells: The role of oxidative stress and mitochondria Biofactors 2005, 23:107-120. 16179752
10. Ostrakhovitch EA Cherian MG Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells Apoptosis 2005, 10:111-121. 10.1007/s10495-005-6066-7 15711927
11. Cousins RJ Liuzzi JP Lichten LA Mammalian zinc transport, trafficking, and signals J Biol Chem 2006, 281:24085-24089. 10.1074/jbc.R600011200 16793761
12. Roesijadi G Bogumil R Vasak M Kagi JH Modulation of DNA binding of a tramtrack zinc finger peptide by the metallothionein-thionein conjugate pair J Biol Chem 1998, 273:17425-17432. 10.1074/jbc.273.28.17425 9651329
13. Hasumi M Suzuki K Matsui H Koike H Ito K Yamanaka H Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues Cancer Lett 2003, 200:187-195. 10.1016/ S0304-3835(03)00441-5 14568174
14. Theocharis SE Margeli AP Klijanienko JT Kouraklis GP Metallothionein expression in human neoplasia Histopathology 2004, 45:103-118. 10.1111/ j.1365-2559.2004.01922.x 15279628
15. Coyle P Philcox JC Carey LC Rofe AM Metallothionein: The multipurpose protein Cell Mol Life Sci 2002, 59:627-647. 10.1007/s00018-002-8454-2 12022471
16. Margoshes M Vallee BL A cadmium protein from equine kidney cortex J.Am.Chem.Soc. 1957, 79:4813-4814. http://pubs.acs.org/cgi-bin/ archive.cgi/jacsat/1957/79/i17/pdf/ja01574a064.pdf
17. Theocharis S Karkantaris C Philipides T Agapitos E Gika A Margeli A Kittas C Koutselinis A Expression of metallothionein in lung carcinoma: correlation with histological type and grade Histopathology 2002, 40:143-151. 10.1046/j.1365-2559.2002.01325.x 11952858
18. Uchida Y Takio K Titani K Ihara Y Tomonaga M The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein Neuron 1991, 7:337-347. 10.1016/ 0896-6273(91)90272-2 1873033
19. Dutta R Sens DA Somji S Sens MA Garrett SH Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells Prostate 2002, 52:89-97. 10.1002/pros.10097 12111700
20. Aschner M Syversen T Souza DO Rocha JB Metallothioneins: Mercury species-specific induction and their potential role in attenuating neurotoxicity Exp Biol Med (Maywood) 2006, 231:1468-1473. 17018868
21. Quaife CJ Findley SD Erickson JC Froelick GJ Kelly EJ Zambrowicz BP Palmiter RD Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia Biochemistry 1994, 33:7250-7259. 10.1021/bi00189a029 8003488
22. Bourdineaud JP Baudrimont M Gonzalez P Moreau JL Challenging the model for induction of metallothionein gene expression Biochimie 2006, 88:1787-1792. 10.1016/j.biochi.2006.07.021 16935407
23. Yin H Smith M Glass J Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity Prostate 2005, 62:209-216. 10.1002/pros.20136 15389791
24. Palmiter RD Findley SD Whitmore TE Durnam DM MT-III, a brain-specific member of the metallothionein gene family Proc Natl Acad Sci U S A 1992, 89;6333-6337. 49495 1631128 10.1073/pnas.89.14.6333
25. Marr MT Isogai Y Wright KJ Tjian R Coactivator cross-talk specifies transcriptional output Genes Dev 2006, 20:1458-1469. 1475759 16751183 10.1101/gad.1418806
26. Wright KJ Marr MT Tjian R TAF4 nucleates a core subcomplex of TFIID and mediates activated transcription from a TATA-less promoter Proc Natl Acad Sci U S A 2006, 103:12347-12352. 1567882 16895980 10.1073/ pnas.0605499103
27. Datta J Majumder S Kutay H Motiwala T Frankel W Costa R Cha HC MacDougald OA Jacob ST Ghoshal K Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade Cancer Res 2007, 67:2736-2746. 10.1158/0008-5472.CAN-06-4433 17363595
28. Jacob ST Majumder S Ghoshal K Suppression of metallothionein-I/II expression and its probable molecular mechanisms Environ Health Perspect 2002, 110(Suppl 5):827-830. 1241254 12426140
29. Bataineh ZM Nusier MK Metallothionein expression in human prostate gland Saudi Med J 2003, 24:1246-1249. 14647563
30. Zhang XH Jin L Sakamoto H Takenaka I Immunohistochemical localization of metallothionein in human prostate cancer J Urol 1996, 156:1679-1681. 10.1016/S0022-5347(01)65481-8 8863569
31. El Sharkawy SL Abbas NF Badawi MA El Shaer MA Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions J Clin Pathol 2006, 59:1171-1174. 10.1136/jcp.2005.033746 16574721
32. Garrett SH Sens MA Shukla D Flores L Somji S Todd JH Sens DA Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer Prostate 2000, 43:125-135. 10.1002/ (SICI)1097-0045(20000501)43:2<125::AID-PROS7>3.0.CO;2-S 10754528
33. Moussa M Kloth D Peers G Cherian MG Frei JV Chin JL Metallothionein expression in prostatic carcinoma: Correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen Clin Invest Med 1997, 20:371-380. 9413634
34. Amoureux MC Wurch T Pauwels PJ Modulation of metallothionein-III mRNA content and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes Biochem Biophys Res Commun 1995, 214:639-645. 10.1006/bbrc.1995.2334 7677777
35. Hoey JG Garrett SH Sens MA Todd JH Sens DA Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma Toxicol Lett 1997, 92:149-160. 10.1016/S0378-4274(97)00049-0 9295238
36. Garrett SH Sens MA Todd JH Somji S Sens DA Expression of MT-3 protein in the human kidney Toxicol Lett 1999, 105:207-214. 10.1016/ S0378-4274(99)00003-X 10355541
37. Garrett SH Sens MA Shukla D Nestor S Somji S Todd JH Sens DA Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines Prostate 1999, 41:196-202. 10.1002/ (SICI)1097-0045(19991101)41:3<196::AID-PROS7>3.0.CO;2-U 10517878
38. Somji S Garrett SH Sens MA Gurel V Sens DA Expression of metallothionein isoform 3 (MT-3) determines the choice between apoptotic or necrotic cell death in Cd+2-exposed human proximal tubule cells Toxicol Sci 2004, 80:358-366. 10.1093/toxsci/kfh158 15129022
39. Somji S Garrett SH Sens MA Sens DA The unique N-terminal sequence of metallothionein-3 is required to regulate the choice between apoptotic or necrotic cell death of human proximal tubule cells exposed to Cd+2 Toxicol Sci 2006, 90:369-376. 10.1093/toxsci/kfj089 16387743
40. Franklin RB Feng P Milon B Desouki MM Singh KK Kajdacsy-Balla A Bagasra O Costello LC hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer Mol Cancer 2005, 4:32. 1243239 16153295 10.1186/1476-4598-4-32
41. Mostofi FK Sesterhenn I Davis CJ Sobin LH Histological typing of prostate tumours Berlin; New York, Springer, 2 International histological classification of tumours 2002